Patient Specific Implant in Postmucormycosis Maxillectomy Patient - Review Article

Abstract

Rhino-maxillary mucormycosis, leads significant consequences for affected individuals, especially in post-maxillectomy cases where extensive bone and soft tissue loss occurs. The COVID-19 pandemic further exacerbated the prevalence of this infection. while surgical intervention combined with antifungal therapy remains the cornerstone of mucormycosis management, the resulting maxillofacial defects severely affect function, aesthetics, and overall quality of life. Traditional reconstruction methods often fall short in addressing these complex rehabilitative needs. Development of Patient-Specific Implants offer a promising alternative, ensuring better anatomical fit, improved functional outcomes, and reduced surgical burden.